title: Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2.
authors.forename: Simona
authors.initials: S
authors.lastname: Bossolasco
authors.forename: Silvia
authors.initials: S
authors.lastname: Nozza
authors.forename: Giovanni
authors.initials: G
authors.lastname: Gaiera
authors.forename: Arabella
authors.initials: A
authors.lastname: Bestetti
authors.forename: Adriano
authors.initials: A
authors.lastname: Lazzarin
authors.forename: Paola
authors.initials: P
authors.lastname: Cinque
mesh_terms: D000328:Adult; D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D016054:DNA, Protozoan / Q000032:analysis; D005260:Female; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000008:administration & dosage*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage; D017211:Treatment Failure
chemical_list: D000981:Antiprotozoal Agents; D016054:DNA, Protozoan; D007376:Interleukin-2; D011994:Recombinant Proteins